Invicta Diagnostic Limited IPO

Apply 0
Avoid 0

Invicta Diagnostics Limited, operating under the brand “PC Diagnostics”, is a diagnostic chain in the Mumbai Metropolitan Region (MMR) offering radiology and pathology services. The company provides imaging solutions, clinical laboratory testing, and teleradiology services through a digitally driven model focused on accessibility, affordability, and quality customer care.

Business Model & Customer Base

The company operates predominantly in the B2C segment, with ~87% of revenue generated from individual patients in FY25. The strategy focuses on:

1. Direct customer engagement
2. Affordable one-stop diagnostics under one roof
3. Home collection and digital access to reports

Products & Services

Invicta offers a diverse diagnostic portfolio with:

i) ~60 routine and 487 specialized pathology tests

ii) ~96 basic and ~130 advanced radiology tests

Services range from basic tests such as X-rays, Ultrasounds, ECGs to advanced modalities like MRI, CT Scan, and PET-CT, supported with home collection and digital reporting to enhance patient convenience.

Operational Network

Invicta follows a Hub-and-Spoke model, ensuring centralized quality control and wider reach. As of September 30, 2025, the network includes:

–  1 flagship centre (main hub) in Thane

– 3 hub centres (with MRI/CT/PET-CT)

– 3 spoke centres for basic testing and sample collection

– 1 centralized laboratory

The diagnostic services are managed by a professional team comprising 20 radiologists, 4 laboratory doctors, and 133 technical staff.

Market Opportunity & Growth Outlook

The Indian diagnostics industry has experienced strong growth driven by ageing population, rising non-communicable diseases, medical tourism, and urbanization. Radiology holds a significant share of India’s diagnostic market and is projected to expand at a ~13.5% CAGR through 2030, presenting a strong opportunity for Invicta’s radiology-led business expansion.

Objects of the Invicta Diagnostic Limited IPO:

Company proposes to utilize the Net Proceeds towards the following objects: 1. Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra (₹21.13 cr) 2. General corporate purposes.

Invicta Diagnostic Limited IPO Details:

Open Date: Dec 01 2025
Close Date: Dec 03 2025
Total Shares: 33,08,800
Face Value: ₹ 10 Per Equity Share
Issue Type: Book Builidng
Issue Size: 28.12 Cr.
Lot Size: 1600 Shares
Issue Price: ₹ 80 - 85 Per Equity Share
Listing At: NSE Emerge
Listing Date: Dec 08 2025

Promoters And Management:

1. Dr. Ketan Jayantilal Jain, Non-Executive Director, holds an MBBS from MUHS Nashik and a Diploma in Medical Radiology & Electrology from CPS Mumbai. With over 16 years of radiology experience, he founded and operated Asian Imaging for more than a decade. He has been associated with our group and the Company since 2021, focusing on quality assurance and regulatory compliance of diagnostic centres. 2. Dr. Sanket Vinod Jain, Chairman & Non-Executive Director, holds an MBBS from MGM Institute of Health Sciences and an MD (Radiodiagnosis) from Bharati Vidyapeeth University. He has around 6 years of radiology experience and has been associated with our group companies and the Company since 2019, overseeing diagnostic imaging, reporting accuracy, and clinical collaboration. 3. Mr. Aayush Kamleshbhai Shah, Independent Director, is an Associate Member of ICSI with degrees in Law and Commerce from Gujarat University. With 10 years of experience in corporate and securities laws, governance, FEMA compliance, capital markets, and listing regulations, he has been serving as Whole-time Company Secretary of Wealth First Portfolio Managers Limited since 2015.

Financials of Invicta Diagnostic Limited IPO:

Particulars 6M FY2025-26 FY 2024-25 FY 2023-2024
Revenue from Operations (Cr) 16.94 30.09 15.83
EBITDA (Cr) 6.76 9.19 7.08
EBITDA Margins 39.92% 30.57% 44.77%
PAT (Cr) 4.08 4.92 3.8
PAT Margins 24.10% 16.38% 24.04%
ROCE 22.80% 42.00% 56.04%
OPerating Cash Flow 5.01 6.55 6.36
Debt to Equity Ratio(In Times) 0.16 0.26 0.44

Comparison With Peers:

Companies Revenue (in cr) EBITDA Margins PAT Margins ROCE D/E Ratio MCap (in cr) P/E
Invicta Diagnostic Limited 30.09 30.57% 16.38% 42.00% 0.26 106.86 21.72
Vijaya Diagnostic Centre Limited 681 40% 21% 20.90% 0.42 10295 67.50
Krsnaa Diagnostics Limited 682 29% 12% 13% 0.3 2628 30.8
NOTE:Forward P/E is 13.09 According to FY 2026 PAT

Lead Manager of Invicta Diagnostic Limited IPO:

  1. Socradamus Capital Private Limited

Registrar of Invicta Diagnostic Limited IPO:

  1. Bigshare Services Private Limited

Discussion on Invicta Diagnostic Limited IPO:

Leave a Reply